MedPath

Role of CT Scan for the Successful Recanalization of Chronic Total Occlusion; a Randomized Comparison Between 3D CT-guided PCI vs. Conventional Treatment (CT-CTO Trial)

Not Applicable
Conditions
Chronic Total Occlusion Lesions
Coronary Artery Obstructive Disease
Interventions
Device: Pre-PCI coronary CT scan
Registration Number
NCT02037698
Lead Sponsor
Yonsei University
Brief Summary

The revascularization of chronic total occlusion of coronary arteries (CTO) is the most challenging procedure for the coronary intervention. For the initial period for CTO intervention, percutaneous coronary artery intervention (PCI) of CTO lesions are associated with low procedural success rates about 70%. Recently, the success rate of the recanalization of CTOs has been raised in several studies.

Coronary CT angiography (CCTA) is an effective noninvasive diagnostic modality for detecting coronary artery disease. CCTA can visualize the complete anatomy of coronary arteries in contrast to conventional coronary angiography, reducing the deferral rates from CTO intervention. Assessment of characteristics of CTO lesions by pre-procedural CCTA could help to determine revascularization strategy and estimate the procedure time, leading to lower procedural complications. We suggest that success rates and clinical outcome of intervention of CTO lesion can be improved by pre-procedural CCTA.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients (age >19 years) with CTO (TIMI = 0 and estimated duration of occlusion at least 3 months)
  • Typical symptomatic angina or positive stress test in various functional studies evaluating ischemia
  • Eligible patients for pre-procedural CT scan and coronary angiogram
Read More
Exclusion Criteria
  • Cardiogenic shock or ejection fraction < 25%
  • CTO lesions at DES restenosis or graft occlusion lesion
  • Significant left main stenosis
  • Retry of same CTO lesion within 2 weeks
  • Acute myocardial infarction within 48 hours
  • Hypersensitivity to aspirin, clopidogrel, or -limus families / or contraindication to antiplatelet agents
  • Severe hepatic dysfunction (≥3 times normal reference values)
  • Life expectancy < 1 years
  • Pregnant women or women with potential childbearing
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pre-PCI CT scan groupPre-PCI coronary CT scanPre-PCI CT scan
Primary Outcome Measures
NameTimeMethod
Successful CTO recanalizationImmediately after CTO PCI

Incidence of the successful CTO recanalization between pre-PCI CT scan group versus control group

Secondary Outcome Measures
NameTimeMethod
Incidence of MACEs12 months after index PCI

Comparison of major adverse cardiac events (MACE), between ZES and EES implantation.

Trial Locations

Locations (1)

Division of Cardiology, Severance Cardiovascular Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath